Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
370
-
Total 13F shares, excl. options
-
141M
-
Shares change
-
+3.34M
-
Total reported value, excl. options
-
$7.74B
-
Value change
-
+$248M
-
Put/Call ratio
-
0.22
-
Number of buys
-
218
-
Number of sells
-
-126
-
Price
-
$54.96
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2025
439 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q3 2025.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 370 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141M shares
.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (19.1M shares), BlackRock, Inc. (15.5M shares), FMR LLC (13.1M shares), VANGUARD GROUP INC (11.9M shares), WELLINGTON MANAGEMENT GROUP LLP (7.41M shares), STATE STREET CORP (5.62M shares), Deep Track Capital, LP (4.3M shares), BANK OF AMERICA CORP /DE/ (3.06M shares), GEODE CAPITAL MANAGEMENT, LLC (3.04M shares), and Polar Capital Holdings Plc (2.78M shares).
This table shows the top 370 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.